Sanzyme Biologics is a group company of Sanzyme Private Limited (Founded as Uni-Sankyo in 1969, first Indo-Japanese joint venture). Sanzyme is a pioneer in fermentation technology with 50 years of legacy in the area of probiotics. It was the first company to launch probiotics in India and today a market leader with presence in over 35 countries across the globe including key markets such as US, Europe, Japan, South Korea, Australia, New Zealand and Taiwan.
Sanzyme Biologics manufactures aerobic spore formers (Bacillus coagulans, Bacillus clausii, and Bacillus subtilis), aerobic vegetative strains (lactobacillus spp. etc.) and yeast (Saccharomyces boulardii) in its world class facility at Hyderabad, India. It adopts proprietary technology and has a sound selection of strains meeting global standards.
Its flagship Bacillus coagulans SNZ 1969 strain is an aerobic spore-forming, lactic acid-producing probiotic bacteria. SNZ 1969 spores are robust and offers flexibility to food, supplement, and pharma product formulators. It sustains processing conditions, gut pH, bile salt and does not require cold chain unlike vegetative probiotic strains. It has US FDA GRAS (including infants), Health Canada approval, Non-GMO project verified and supported with 25 plus scientific publications around gut health, oral health, and women’s health.
Brands: Bacillus coagulans SNZ 1969|Bacillus clausii SNZ 1971|Bacillus subtilis SNZ 1972|Saccharomyces boulardii SNZ 1986
Additional Info
Association Memberships:
(select all applicable)
International Probiotics Association (IPA)Certifications & Quality Control Data:
(select all applicable)
Certified Gluten-free, Certified GMP, Certified Halal, Certified ISO, Certified Kosher, Certified Non-GMO, Offer Clean Label Solutions, Provide Formulation/R&D Support, Use Independent Analytical Lab, Use In-House Analytical LabExporting Status:
YesExporting Interest:
Direct Sales, Foreign Agents/DistributorsGeographic Area of Interest:
All Geographic Areas